Preliminary clinical investigations of high-dose furmonertinib in NSCLC with EGFR Exon 20 insertions (20ins).

Lin, Y; Hu, ZH; Zhang, Y; Sun, S; Yu, H; Zhao, XM; Wu, XH; Wang, HJ; Wang, JL

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):